Výsledky vyhledávání - "D. L. Kendler"

Trends in osteoporosis care patterns during the COVID-19 pandemic in Alberta, Canada

Autor: T. Oliveira, J. Brown, A. G. Juby, P. Schneider, R. J. Wani, M. Packalen, S. Avcil, S. Li, M. Farris, E. Graves, S. McMullen, D. L. Kendler

Publikováno v: Archives of osteoporosis. 17(1)

Purpose/introduction The objective of this study was to describe osteoporosis-related care patterns during the coronavirus disease 2019 (COVID-19) pandemic in Alberta, Canada, relative to the 3-year preceding. Methods A repeated cross-sectional study

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a5048f0193087112a29c79a718fe57f
https://pubmed.ncbi.nlm.nih.gov/35920939

Zobrazit plný text záznamu

Trends in osteoporotic fracture and related in-hospital complications during the COVID-19 pandemic in Alberta, Canada

Autor: T. Oliveira, D. L. Kendler, P. Schneider, A. G. Juby, R. J. Wani, M. Packalen, S. Avcil, S. Li, C. Waters-Banker, E. Graves, S. McMullen, J. Brown

Publikováno v: Archives of osteoporosis. 17(1)

Summary Fragility fractures (i.e., low-energy fractures) account for most fractures among older Canadians and are associated with significant increases in morbidity and mortality. Study results suggest that low-energy fracture rates (associated with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22e7dd960e037045b41612c26bba99f5
https://pubmed.ncbi.nlm.nih.gov/35920903

Zobrazit plný text záznamu

Efficacy of teriparatide compared with risedronate on FRAX

Autor: J-J, Body, F, Marin, D L, Kendler, C A F, Zerbini, P, López-Romero, R, Möricke, E, Casado, A, Fahrleitner-Pammer, J J, Stepan, E, Lespessailles, S, Minisola, P, Geusens

Publikováno v: Osteoporosis International

Summary FRAX® calculates the 10-year probability of major osteoporotic fractures (MOF), which are considered to have a greater clinical impact than other fractures. Our results suggest that, in postmenopausal women with severe osteoporosis, those tr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a70dd56e36bafacfe722d044a338d738
https://pubmed.ncbi.nlm.nih.gov/32474650

Zobrazit plný text záznamu

Build better bones with exercise (B3E pilot trial): results of a feasibility study of a multicenter randomized controlled trial of 12 months of home exercise in older women with vertebral fracture

Autor: L M, Giangregorio, J C, Gibbs, J A, Templeton, J D, Adachi, M C, Ashe, R R, Bleakney, A M, Cheung, K D, Hill, D L, Kendler, A A, Khan, S, Kim, C, McArthur, N, Mittmann, A, Papaioannou, S, Prasad, S C, Scherer, L, Thabane, J D, Wark

Publikováno v: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 29(11)

We pilot-tested a trial of home exercise on individuals with osteoporosis and spine fracture. Our target enrollment was met, though it took longer than expected. Participants stayed in the study and completed the exercise program with no safety conce

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::04d568779e71fd922db430a3bbe504c6
https://pubmed.ncbi.nlm.nih.gov/30091064

Zobrazit plný text záznamu

Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study

Autor: S L, Silverman, A A, Chines, D L, Kendler, A W C, Kung, C S, Teglbjærg, D, Felsenberg, N, Mairon, G D, Constantine, J D, Adachi, Edward, Zbella

Publikováno v: Osteoporosis International, 23(1), 351-363. Springer-Verlag London Ltd.

In this 2-year extension of a 3-year study, bazedoxifene showed sustained efficacy in preventing new vertebral fractures in postmenopausal women with osteoporosis and in preventing non-vertebral fractures in higher-risk women. Bazedoxifene significan

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cf83d1c6a18f1ef005528eb50c1929d
https://doi.org/10.1007/s00198-011-1691-1

Zobrazit plný text záznamu

Adherence, preference, and satisfaction of postmenopausal women taking denosumab or alendronate

Autor: D L, Kendler, M R, McClung, N, Freemantle, M, Lillestol, A H, Moffett, J, Borenstein, S, Satram-Hoang, Y-C, Yang, P, Kaur, D, Macarios, S, Siddhanti, Jerieta, Waltin-James

Publikováno v: Osteoporosis International. 22:1725-1735

In this study, 250 women with osteoporosis were randomized to 12 months with subcutaneous denosumab 60 mg every 6 months or oral alendronate 70 mg once weekly, then crossed over to the other treatment. The primary endpoint, treatment adherence at 12

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bba4a293c67033bbc63b5bdfe166a9be
https://doi.org/10.1007/s00198-010-1378-z

Zobrazit plný text záznamu

Pharmaceutical care and community pharmacists' understanding of bisphosphonate dosing information1

Autor: D. L. Kendler, W. W. Li

Publikováno v: Journal of Clinical Pharmacy and Therapeutics. 29:531-536

Summary Objectives: To evaluate pharmacists’ knowledge of approved dosing information for cyclic etidronate, alendronate and risedronate in the treatment of postmenopausal osteoporosis; and to assess its relationship to demographic and pharmaceutic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0a25b32c604addeb9af162d4573ddebf
https://doi.org/10.1111/j.1365-2710.2004.00597.x

Zobrazit plný text záznamu

A community-based clinical trial of Intra-Venous zOledRonic acid once Yearly in comparison to oral bisphosphonates in postmenopausal women with osteoporosis: the IVORY trial Methodological considerations

Autor: Jacques P, Brown, J D, Adachi, D L, Kendler, R, Rigal, G, Deutsch, J M, Leclerc

Publikováno v: Contemporary clinical trials. 32(5)

Zoledronic acid is an intravenous once yearly bisphosphonate that has been shown to be effective and safe in improving BMD (bone mineral density) and reducing fracture risk in controlled clinical trials. IVORY is a Canadian post marketing study aimin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::75304ab9b0793ba759b2a3d9d69221bc
https://pubmed.ncbi.nlm.nih.gov/21628001

Zobrazit plný text záznamu

Pharmaceutical care and community pharmacists' understanding of bisphosphonate dosing information

Autor: W W, Li, D L, Kendler

Publikováno v: Journal of clinical pharmacy and therapeutics. 29(6)

To evaluate pharmacists' knowledge of approved dosing information for cyclic etidronate, alendronate and risedronate in the treatment of postmenopausal osteoporosis; and to assess its relationship to demographic and pharmaceutical care factors.Fax-ba

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4b579e7e593339f48173742305fa4cd6
https://pubmed.ncbi.nlm.nih.gov/15584941

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání